{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T11:06:52Z","timestamp":1792667212802,"version":"4.5.0"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,21]],"date-time":"2025-11-21T00:00:00Z","timestamp":1763683200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,1,16]],"date-time":"2026-01-16T00:00:00Z","timestamp":1768521600000},"content-version":"vor","delay-in-days":56,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Death Dis"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disease of motor neurons, leading to fatal muscle paralysis. Familial forms of ALS (fALS) account for approximately 10% of cases. Alterations of mitochondrial functions have been proposed to contribute to disease pathogenesis. Here, we employed a direct conversion (DC) technique to generate induced motor neurons (iMN) from skin fibroblasts to investigate mitochondrial phenotypes in a patient-derived disease relevant cell culture system. We converted 7 control fibroblast lines and 17 lines harboring the following fALS mutations, SOD1\n                    <jats:sup>A4V<\/jats:sup>\n                    , TDP-43\n                    <jats:sup>N352S<\/jats:sup>\n                    , FUS\n                    <jats:sup>R521G<\/jats:sup>\n                    , CHCHD10\n                    <jats:sup>R15L<\/jats:sup>\n                    , and C9orf72 repeat expansion. We developed new machine learning approaches to identify iMN, analyze their mitochondrial function, and follow their fate longitudinally. Mitochondrial and energetic abnormalities were observed, but not all fALS iMN lines exhibited the same alterations. SOD1\n                    <jats:sup>A4V<\/jats:sup>\n                    , C9orf72, and TDP-43\n                    <jats:sup>N352S<\/jats:sup>\n                    iMN had increased mitochondrial membrane potential, while in CHCHD10\n                    <jats:sup>R15L<\/jats:sup>\n                    cells membrane potential was decreased. TDP-43\n                    <jats:sup>N352S<\/jats:sup>\n                    iMN displayed changes in mitochondrial morphology and increased motility. SOD1\n                    <jats:sup>A4V<\/jats:sup>\n                    , TDP-43\n                    <jats:sup>N352S<\/jats:sup>\n                    , and CHCHD10\n                    <jats:sup>R15L<\/jats:sup>\n                    iMN had increased oxygen consumption rates and altered extracellular acidification rates. FUS\n                    <jats:sup>R521G<\/jats:sup>\n                    mutants had decreased ATP\/ADP ratio, suggesting impaired energy metabolism. SOD1\n                    <jats:sup>A4V<\/jats:sup>\n                    , C9orf72, and TDP-43\n                    <jats:sup>N352S<\/jats:sup>\n                    had increased, while FUS\n                    <jats:sup>R521G<\/jats:sup>\n                    had decreased mitochondrial reactive oxygen species production. We tested the viability of iMN and found decreases in survival in SOD1\n                    <jats:sup>A4V<\/jats:sup>\n                    , C9orf72, and FUS\n                    <jats:sup>R521G<\/jats:sup>\n                    , which were corrected by small molecules that target mitochondrial stress and worsened by bioenergetic stressors. Together, our findings reinforce the role of mitochondrial dysfunction in ALS and indicate that fibroblast-derived iMN may be useful to study fALS metabolic alterations. Strengths of the DC iMN approach include low cost, speed of transformation, and the preservation of epigenetic modifications. However, further refinement of the fibroblasts DC iMN technique is still needed to improve transformation efficiency, reproducibility, the relatively short lifespan of iMN, and the senescence of the parental fibroblasts.\n                  <\/jats:p>","DOI":"10.1038\/s41419-025-08126-6","type":"journal-article","created":{"date-parts":[[2025,11,21]],"date-time":"2025-11-21T19:05:36Z","timestamp":1763751936000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Investigation of mitochondrial phenotypes in motor neurons derived by direct conversion of fibroblasts from familial ALS subjects"],"prefix":"10.1038","volume":"17","author":[{"given":"Evan","family":"Woo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Faiza","family":"Tasnim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0020-6933","authenticated-orcid":false,"given":"Hibiki","family":"Kawamata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanni","family":"Manfredi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1157-4574","authenticated-orcid":false,"given":"Csaba","family":"Konrad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,21]]},"reference":[{"key":"8126_CR1","doi-asserted-by":"publisher","first-page":"805","DOI":"10.3233\/JAD-230119","volume":"95","author":"R Sattarov","year":"2023","unstructured":"Sattarov R, Toresson H, Orbjorn C, Mattsson-Carlgren N. Direct conversion of fibroblast into neurons for Alzheimer\u2019s disease research: a systematic review. J Alzheimers Dis. 2023;95:805\u201328.","journal-title":"J Alzheimers Dis"},{"key":"8126_CR2","doi-asserted-by":"publisher","first-page":"10945","DOI":"10.18632\/oncotarget.14641","volume":"8","author":"QJ Zhang","year":"2017","unstructured":"Zhang QJ, Li JJ, Lin X, Lu YQ, Guo XX, Dong EL, et al. Modeling the phenotype of spinal muscular atrophy by the direct conversion of human fibroblasts to motor neurons. Oncotarget. 2017;8:10945\u201353.","journal-title":"Oncotarget"},{"key":"8126_CR3","doi-asserted-by":"publisher","first-page":"359","DOI":"10.3389\/fnmol.2017.00359","volume":"10","author":"Y Tang","year":"2017","unstructured":"Tang Y, Liu ML, Zang T, Zhang CL. Direct reprogramming rather than iPSC-based reprogramming maintains aging hallmarks in human motor neurons. Front Mol Neurosci. 2017;10:359.","journal-title":"Front Mol Neurosci"},{"key":"8126_CR4","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1089\/cell.2021.0172","volume":"24","author":"EM Legault","year":"2022","unstructured":"Legault EM, Bouquety J, Drouin-Ouellet J. Disease modeling of neurodegenerative disorders using direct neural reprogramming. Cell Reprogram. 2022;24:228\u201351.","journal-title":"Cell Reprogram"},{"key":"8126_CR5","doi-asserted-by":"publisher","DOI":"10.3389\/fnagi.2022.1069482","volume":"14","author":"S Aversano","year":"2022","unstructured":"Aversano S, Caiazza C, Caiazzo M. Induced pluripotent stem cell-derived and directly reprogrammed neurons to study neurodegenerative diseases: the impact of aging signatures. Front Aging Neurosci. 2022;14:1069482.","journal-title":"Front Aging Neurosci"},{"key":"8126_CR6","doi-asserted-by":"publisher","first-page":"1639","DOI":"10.4103\/1673-5374.389639","volume":"19","author":"S Ma","year":"2024","unstructured":"Ma S, Zhang CL. MAP4K inhibition as a potential therapy for amyotrophic lateral sclerosis. Neural Regen Res. 2024;19:1639\u201340.","journal-title":"Neural Regen Res"},{"key":"8126_CR7","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-023-06395-7","volume":"15","author":"ML Liu","year":"2024","unstructured":"Liu ML, Ma S, Tai W, Zhong X, Ni H, Zou Y, et al. Screens in aging-relevant human ALS-motor neurons identify MAP4Ks as therapeutic targets for the disease. Cell Death Dis. 2024;15:4.","journal-title":"Cell Death Dis"},{"key":"8126_CR8","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1186\/s13024-016-0075-6","volume":"11","author":"SM Lim","year":"2016","unstructured":"Lim SM, Choi WJ, Oh KW, Xue Y, Choi JY, Kim SH, et al. Directly converted patient-specific induced neurons mirror the neuropathology of FUS with disrupted nuclear localization in amyotrophic lateral sclerosis. Mol Neurodegener. 2016;11:8.","journal-title":"Mol Neurodegener"},{"key":"8126_CR9","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/j.celrep.2015.12.018","volume":"14","author":"ML Liu","year":"2016","unstructured":"Liu ML, Zang T, Zhang CL. Direct lineage reprogramming reveals disease-specific phenotypes of motor neurons from human ALS patients. Cell Rep. 2016;14:115\u201328.","journal-title":"Cell Rep"},{"key":"8126_CR10","doi-asserted-by":"publisher","first-page":"935","DOI":"10.3389\/fnins.2019.00935","volume":"13","author":"PO Bauer","year":"2019","unstructured":"Bauer PO, Dunmore JH, Sasaguri H, Matoska V. Neurons induced from fibroblasts of c9ALS\/FTD patients reproduce the pathology seen in the central nervous system. Front Neurosci. 2019;13:935.","journal-title":"Front Neurosci"},{"key":"8126_CR11","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1038\/s41593-018-0293-z","volume":"22","author":"Z Melamed","year":"2019","unstructured":"Melamed Z, Lopez-Erauskin J, Baughn MW, Zhang O, Drenner K, Sun Y, et al. Premature polyadenylation-mediated loss of stathmin-2 is a hallmark of TDP-43-dependent neurodegeneration. Nat Neurosci. 2019;22:180\u201390.","journal-title":"Nat Neurosci"},{"key":"8126_CR12","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1016\/bs.irn.2024.04.006","volume":"176","author":"J Lee","year":"2024","unstructured":"Lee J, Pye N, Ellis L, Vos K, Mortiboys H. Evidence of mitochondrial dysfunction in ALS and methods for measuring in model systems. Int Rev Neurobiol. 2024;176:269\u2013325.","journal-title":"Int Rev Neurobiol"},{"key":"8126_CR13","doi-asserted-by":"publisher","first-page":"126","DOI":"10.3390\/genes14111981","volume":"14","author":"EC Genin","year":"2023","unstructured":"Genin EC, Abou-Ali M, Paquis-Flucklinger V. Mitochondria, a key target in amyotrophic lateral sclerosis pathogenesis. Genes. 2023;14:126.","journal-title":"Genes"},{"key":"8126_CR14","doi-asserted-by":"publisher","first-page":"620","DOI":"10.1002\/ana.24244","volume":"76","author":"K Kirk","year":"2014","unstructured":"Kirk K, Gennings C, Hupf JC, Tadesse S, D\u2019Aurelio M, Kawamata H, et al. Bioenergetic markers in skin fibroblasts of sporadic amyotrophic lateral sclerosis and progressive lateral sclerosis patients. Ann Neurol. 2014;76:620\u20134.","journal-title":"Ann Neurol"},{"key":"8126_CR15","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1186\/s13024-017-0217-5","volume":"12","author":"C Konrad","year":"2017","unstructured":"Konrad C, Kawamata H, Bredvik KG, Arreguin AJ, Cajamarca SA, Hupf JC, et al. Fibroblast bioenergetics to classify amyotrophic lateral sclerosis patients. Mol Neurodegener. 2017;12:76.","journal-title":"Mol Neurodegener"},{"key":"8126_CR16","doi-asserted-by":"publisher","first-page":"1551","DOI":"10.1002\/acn3.51648","volume":"9","author":"JA Fels","year":"2022","unstructured":"Fels JA, Dash J, Leslie K, Manfredi G, Kawamata H. Effects of PB-TURSO on the transcriptional and metabolic landscape of sporadic ALS fibroblasts. Ann Clin Transl Neurol. 2022;9:1551\u201364.","journal-title":"Ann Clin Transl Neurol"},{"key":"8126_CR17","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1016\/j.neurobiolaging.2023.06.010","volume":"130","author":"E Woo","year":"2023","unstructured":"Woo E, Bredvik K, Liu B, Fuchs TJ, Manfredi G, Konrad C. Machine learning approaches based on fibroblast morphometry do not predict ALS. Neurobiol Aging. 2023;130:80\u20133.","journal-title":"Neurobiol Aging"},{"key":"8126_CR18","doi-asserted-by":"publisher","first-page":"3458","DOI":"10.1093\/hmg\/ddac118","volume":"31","author":"JA Fels","year":"2022","unstructured":"Fels JA, Casalena G, Konrad C, Holmes HE, Dellinger RW, Manfredi G. Gene expression profiles in sporadic ALS fibroblasts define disease subtypes and the metabolic effects of the investigational drug EH301. Hum Mol Genet. 2022;31:3458\u201377.","journal-title":"Hum Mol Genet"},{"key":"8126_CR19","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1016\/j.stem.2017.08.002","volume":"21","author":"DG Abernathy","year":"2017","unstructured":"Abernathy DG, Kim WK, McCoy MJ, Lake AM, Ouwenga R, Lee SW, et al. MicroRNAs induce a permissive chromatin environment that enables neuronal subtype-specific reprogramming of adult human fibroblasts. Cell Stem Cell. 2017;21:332\u201348.e9.","journal-title":"Cell Stem Cell"},{"key":"8126_CR20","doi-asserted-by":"publisher","first-page":"824","DOI":"10.1080\/09168451.2019.1574204","volume":"83","author":"PTM Nguyen","year":"2019","unstructured":"Nguyen PTM, Ishiwata-Kimata Y, Kimata Y. Monitoring ADP\/ATP ratio in yeast cells using the fluorescent-protein reporter PercevalHR. Biosci Biotechnol Biochem. 2019;83:824\u20138.","journal-title":"Biosci Biotechnol Biochem"},{"key":"8126_CR21","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.abf8142","volume":"7","author":"JW Linsley","year":"2021","unstructured":"Linsley JW, Linsley DA, Lamstein J, Ryan G, Shah K, Castello NA, et al. Superhuman cell death detection with biomarker-optimized neural networks. Sci Adv. 2021;7:eabf8142.","journal-title":"Sci Adv"},{"key":"8126_CR22","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1007\/s00401-007-0206-9","volume":"113","author":"CF Tan","year":"2007","unstructured":"Tan CF, Eguchi H, Tagawa A, Onodera O, Iwasaki T, Tsujino A, et al. TDP-43 immunoreactivity in neuronal inclusions in familial amyotrophic lateral sclerosis with or without SOD1 gene mutation. Acta Neuropathol. 2007;113:535\u201342.","journal-title":"Acta Neuropathol"},{"key":"8126_CR23","doi-asserted-by":"publisher","DOI":"10.1212\/NXG.0000000000000394","volume":"6","author":"JL Keith","year":"2020","unstructured":"Keith JL, Swinkin E, Gao A, Alminawi S, Zhang M, McGoldrick P, et al. Neuropathologic description of CHCHD10 mutated amyotrophic lateral sclerosis. Neurol Genet. 2020;6:e394.","journal-title":"Neurol Genet"},{"key":"8126_CR24","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1126\/scitranslmed.abe1923","volume":"13","author":"AN Coyne","year":"2021","unstructured":"Coyne AN, Baskerville V, Zaepfel BL, Dickson DW, Rigo F, Bennett F, et al. Nuclear accumulation of CHMP7 initiates nuclear pore complex injury and subsequent TDP-43 dysfunction in sporadic and familial ALS. Sci Transl Med. 2021;13:5.","journal-title":"Sci Transl Med"},{"key":"8126_CR25","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1111\/nan.12292","volume":"42","author":"Y Davidson","year":"2016","unstructured":"Davidson Y, Robinson AC, Liu X, Wu D, Troakes C, Rollinson S, et al. Neurodegeneration in frontotemporal lobar degeneration and motor neurone disease associated with expansions in C9orf72 is linked to TDP-43 pathology and not associated with aggregated forms of dipeptide repeat proteins. Neuropathol Appl Neurobiol. 2016;42:242\u201354.","journal-title":"Neuropathol Appl Neurobiol"},{"key":"8126_CR26","doi-asserted-by":"crossref","unstructured":"Martin EJ, Santacruz C, Mitevska A, Jones IE, Krishnan G, Gao FB, et al. Traumatic injury causes selective degeneration and TDP-43 mislocalization in human iPSC-derived C9orf72-associated ALS\/FTD motor neurons. bioRxiv [Preprint]. 2024.","DOI":"10.1101\/2024.03.21.586073"},{"key":"8126_CR27","doi-asserted-by":"publisher","first-page":"550","DOI":"10.3390\/ijms23179652","volume":"23","author":"BP Dash","year":"2022","unstructured":"Dash BP, Freischmidt A, Weishaupt JH, Hermann A. Downstream effects of mutations in SOD1 and TARDBP converge on gene expression impairment in patient-derived motor neurons. Int J Mol Sci. 2022;23:550.","journal-title":"Int J Mol Sci"},{"key":"8126_CR28","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-12099-4","volume":"10","author":"T Vandoorne","year":"2019","unstructured":"Vandoorne T, Veys K, Guo W, Sicart A, Vints K, Swijsen A, et al. Differentiation but not ALS mutations in FUS rewires motor neuron metabolism. Nat Commun. 2019;10:4147.","journal-title":"Nat Commun"},{"key":"8126_CR29","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1016\/j.cmet.2021.01.005","volume":"33","author":"T Wang","year":"2021","unstructured":"Wang T, Liu H, Itoh K, Oh S, Zhao L, Murata D, et al. C9orf72 regulates energy homeostasis by stabilizing mitochondrial complex I assembly. Cell Metab. 2021;33:531\u201346.e9.","journal-title":"Cell Metab"},{"key":"8126_CR30","doi-asserted-by":"publisher","first-page":"20","DOI":"10.3164\/jcbn.17-62","volume":"62","author":"K Watanabe","year":"2018","unstructured":"Watanabe K, Tanaka M, Yuki S, Hirai M, Yamamoto Y. How is edaravone effective against acute ischemic stroke and amyotrophic lateral sclerosis?. J Clin Biochem Nutr. 2018;62:20\u201338.","journal-title":"J Clin Biochem Nutr"},{"key":"8126_CR31","first-page":"1407","volume":"19","author":"Y Pan","year":"2020","unstructured":"Pan Y, Li W, Feng Y, Xu J, Cao H. Edaravone attenuates experimental asthma in mice through induction of HO-1 and the Keap1\/Nrf2 pathway. Exp Ther Med. 2020;19:1407\u201316.","journal-title":"Exp Ther Med"},{"key":"8126_CR32","first-page":"2437","volume":"18","author":"J Liu","year":"2019","unstructured":"Liu J, Jiang Y, Zhang G, Lin Z, Du S. Protective effect of edaravone on blood-brain barrier by affecting NRF-2\/HO-1 signaling pathway. Exp Ther Med. 2019;18:2437\u201342.","journal-title":"Exp Ther Med"},{"key":"8126_CR33","doi-asserted-by":"publisher","DOI":"10.3389\/fnbeh.2021.632143","volume":"15","author":"Z Wu","year":"2021","unstructured":"Wu Z, Niu J, Xue H, Wang S, Zhao P. Sodium 4-phenylbutyrate protects hypoxic-ischemic brain injury via attenuating endoplasmic reticulum stress in neonatal rats. Front Behav Neurosci. 2021;15:632143.","journal-title":"Front Behav Neurosci"},{"key":"8126_CR34","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/0092-8674(78)90305-7","volume":"14","author":"EP Candido","year":"1978","unstructured":"Candido EP, Reeves R, Davie JR. Sodium butyrate inhibits histone deacetylation in cultured cells. Cell. 1978;14:105\u201313.","journal-title":"Cell"},{"key":"8126_CR35","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1007\/s12272-019-01148-7","volume":"42","author":"W Lee","year":"2019","unstructured":"Lee W, Kim SH. Autophagy at synapses in neurodegenerative diseases. Arch Pharm Res. 2019;42:407\u201315.","journal-title":"Arch Pharm Res"},{"key":"8126_CR36","doi-asserted-by":"publisher","first-page":"1073","DOI":"10.1038\/cr.2013.94","volume":"23","author":"GM Pasinetti","year":"2013","unstructured":"Pasinetti GM, Bilski AE, Zhao W. Sirtuins as therapeutic targets of ALS. Cell Res. 2013;23:1073\u20134.","journal-title":"Cell Res"},{"key":"8126_CR37","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1038\/6568","volume":"5","author":"P Klivenyi","year":"1999","unstructured":"Klivenyi P, Ferrante RJ, Matthews RT, Bogdanov MB, Klein AM, Andreassen OA, et al. Neuroprotective effects of creatine in a transgenic animal model of amyotrophic lateral sclerosis. Nat Med. 1999;5:347\u201350.","journal-title":"Nat Med"},{"key":"8126_CR38","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1007\/s00401-022-02494-5","volume":"144","author":"F Pilotto","year":"2022","unstructured":"Pilotto F, Schmitz A, Maharjan N, Diab R, Odriozola A, Tripathi P, et al. PolyGA targets the ER stress-adaptive response by impairing GRP75 function at the MAM in C9ORF72-ALS\/FTD. Acta Neuropathol. 2022;144:939\u201366.","journal-title":"Acta Neuropathol"},{"key":"8126_CR39","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1007\/s00401-020-02252-5","volume":"141","author":"AR Mehta","year":"2021","unstructured":"Mehta AR, Gregory JM, Dando O, Carter RN, Burr K, Nanda J, et al. Mitochondrial bioenergetic deficits in C9orf72 amyotrophic lateral sclerosis motor neurons cause dysfunctional axonal homeostasis. Acta Neuropathol. 2021;141:257\u201379.","journal-title":"Acta Neuropathol"},{"key":"8126_CR40","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1038\/nm.4130","volume":"22","author":"W Wang","year":"2016","unstructured":"Wang W, Wang L, Lu J, Siedlak SL, Fujioka H, Liang J, et al. The inhibition of TDP-43 mitochondrial localization blocks its neuronal toxicity. Nat Med. 2016;22:869\u201378.","journal-title":"Nat Med"},{"key":"8126_CR41","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/j.nbd.2018.03.010","volume":"115","author":"N Kreiter","year":"2018","unstructured":"Kreiter N, Pal A, Lojewski X, Corcia P, Naujock M, Reinhardt P, et al. Age-dependent neurodegeneration and organelle transport deficiencies in mutant TDP43 patient-derived neurons are independent of TDP43 aggregation. Neurobiol Dis. 2018;115:167\u201381.","journal-title":"Neurobiol Dis"},{"key":"8126_CR42","doi-asserted-by":"publisher","first-page":"487","DOI":"10.3389\/fnins.2019.00487","volume":"13","author":"G Pharaoh","year":"2019","unstructured":"Pharaoh G, Sataranatarajan K, Street K, Hill S, Gregston J, Ahn B, et al. Metabolic and stress response changes precede disease onset in the spinal cord of mutant SOD1 ALS mice. Front Neurosci. 2019;13:487.","journal-title":"Front Neurosci"},{"key":"8126_CR43","doi-asserted-by":"publisher","first-page":"1413","DOI":"10.1093\/hmg\/ddt528","volume":"23","author":"J Magrane","year":"2014","unstructured":"Magrane J, Cortez C, Gan WB, Manfredi G. Abnormal mitochondrial transport and morphology are common pathological denominators in SOD1 and TDP43 ALS mouse models. Hum Mol Genet. 2014;23:1413\u201324.","journal-title":"Hum Mol Genet"},{"key":"8126_CR44","doi-asserted-by":"publisher","first-page":"2974","DOI":"10.1093\/hmg\/ddq202","volume":"19","author":"S Pedrini","year":"2010","unstructured":"Pedrini S, Sau D, Guareschi S, Bogush M, Brown RH Jr., Naniche N, et al. ALS-linked mutant SOD1 damages mitochondria by promoting conformational changes in Bcl-2. Hum Mol Genet. 2010;19:2974\u201386.","journal-title":"Hum Mol Genet"}],"container-title":["Cell Death &amp; Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41419-025-08126-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-025-08126-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-025-08126-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,16]],"date-time":"2026-01-16T16:02:47Z","timestamp":1768579367000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41419-025-08126-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,21]]},"references-count":44,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["8126"],"URL":"https:\/\/doi.org\/10.1038\/s41419-025-08126-6","relation":{},"ISSN":["2041-4889"],"issn-type":[{"value":"2041-4889","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,21]]},"assertion":[{"value":"24 December 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 September 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 October 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 November 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"All methods were performed in accordance with relevant guidelines and regulations. Human dermal fibroblast samples were provided to our laboratory as de-identified, coded specimens. Samples originated from the NINDS Repository and collaborating source institutions and were transferred under executed MTAs. Informed consent for participation and sample banking was obtained by the source institutions from all participants prior to de-identification and transfer to our laboratory. No experiments involving live vertebrate animals were conducted in this study. This article does not include any identifiable images or personally identifying information of human participants.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}}],"article-number":"51"}}